Recurrent Neuroblastoma Completed Phase 3 Trials for Isotretinoin (DB00982)

Also known as: Neuroblastoma Recurrent

IndicationStatusPhase
DBCOND0028756 (Recurrent Neuroblastoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs